The Motley Fool

3 top FTSE 100 dividend stocks I’m buying right now

Making money from stocks is not just about capital gains. Dividends play an outsized role in total market returns. Studies show that over the long term, dividends account for more than half of the market’s total return.

But not all dividend stocks are created equal, some have much better income qualities than others. I believe these are the three best income stocks in the FTSE 100 today.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Cash cow

Over the past three years, BP (LSE: BP) has been rebuilding itself. The oil price crash in 2014 forced the company to rethink its operations and slash costs. Today, these efforts are paying off.

With profits surging, management is eager to return as much cash as possible to investors. At the end of last month, alongside its second-quarter results, BP announced its first dividend increase since 2014 as profit quadrupled year-on-year. On top of the dividend increase, the company is also planning to return as much as $6bn to investors via share repurchases.

The market hasn’t really reacted to these plans to return additional capital to investors. Shares in BP have only fallen since the announcement. For income seekers, this is good news because the shares currently support a dividend yield of 5.8%. 

As BP generates more cash than it knows what to do with, I expect the payout to continue growing, which makes this a perfect stock for income hunters.

Defensive income

GlaxoSmithKline (LSE: GSK) is another name on my list of top FTSE 100 income stocks.

Last year, shares in Glaxo plunged when speculation began to emerge that the company was planning a cut to its dividend payout of 80p per share. Even though management has since stated that it is committed to the distribution, investors have been slow to return.

Over the past few months, sentiment has begun to recover. The stock is up around 28% since the beginning of February. New product launches and better than expected sales growth have helped the company regain investor trust. City analysts now believe the group can achieve EPS growth of 17% for the full year. Based on these figures, the shares are trading at a forward P/E of 14.3, an undemanding multiple in my opinion considering Glaxo’s growth potential and defensive nature.

Shares in the company also support a dividend yield of 5.1%. 

Change of direction

ITV (LSE: ITV) is the final dividend stock on my list. With a dividend yield of 5.1% at the time of writing, ITV, along with Glaxo and BP, supports one of the best dividend yields in the FTSE 100.

The shares also trade at an attractive multiple of 10.6 times forward earnings, even though City analysts have pencilled in EPS growth of 9% for 2018. In my opinion, this rate of growth deserves a mid-teens multiple at least.

It would appear investors are concerned about what the future holds for the broadcaster. Recently, the group’s new CEO, Carolyn McCall, announced plans to spend more on content in an attempt to take on US media giants such as Netflix

Only time will tell if this strategy will pay off, but I believe it is the right choice for the group. Without spending more on content, ITV risks being left behind. By investing for the future, it will be able to guarantee its dividend for many years to come.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…

And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...

It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…

But you need to get in before the crowd catches onto this ‘sleeping giant’.

Click here to learn more.

Rupert Hargreaves owns shares in GlaxoSmithKline and ITV. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Netflix. The Motley Fool UK has recommended ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.